Drug use cases:
Significant response to cytodrex has been observed in refractory, stable, and recurrent chronic myeloma and leukemia, as well as non-surgical, recurrent, and metastatic ovarian carcinoma.
Cytodrex is prescribed concomitantly with radiation therapy to regionally control squamous cell carcinoma of the head and neck, excluding the lips.